Collecting real world evidence to achieve product authorisation, accelerate market access, and drive product adoption
With ICON you have access to dedicated outcomes research experts, with deep knowledge and insight to design your study to meet your specific objectives. We design your study with input from leading epidemiologists, medical and scientific affairs experts, COA authors, KOLs and access to Mapi Research Trust.
40years of late phase experience
600+dedicated operational experts
40+expertise in over 40 countries
We understand the unique challenges of late phase research, and deliver an integrated approach to drive your success.
ICON is the industry’s most experienced real patient research organisation, with over 40 years of experience, and 600+ dedicated peri- and post-approval operational experts in 40+ countries.
Our biometrics team is dedicated to late phase research and provides a full range of services and solutions, including:
- Statistics, including statistical analysis plans, study design and additional analyses
- Medical writing to support protocols, study reports and scientific communication
- Data management support for STDM (Study Data Tabulation Model), ADaM (Analysis Data Model) and Listings
- Programming including database design and T/F/L programming
The team includes a range of expertise, including epidemiologists, therapeutic medical advisors, medical monitors and safety specialists.
We design and implement your study with specific milestone and budget guarantees, supported by fully engaged senior leadership governance, and full team, timeline and budget transparency.
Integrated Patient and Site Engagement
Through our collaboration with leading EHR providers, we help identify real patients and the most appropriate research sites. Our dedicated patient engagement and direct to patient contact teams ensure that your patients, sites and investigators are fully engaged throughout the study.
Global Research Services Hubs
Our dedicated global research hubs provide 24/7 support for your studies.Staffed by late phase experts, who are fluent in over 35 languages, they deliver unparalleled global support for interventional trials, pragmatic research, real world research and patient support programs.